US Stock MarketDetailed Quotes

NRBO NeuroBo Pharmaceuticals

Watchlist
  • 3.0600
  • -0.0400-1.29%
Close Apr 25 16:00 ET
  • 3.0600
  • 0.00000.00%
Post 16:21 ET
15.01MMarket Cap-1243P/E (TTM)

NeuroBo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.80%-10.8M
-87.77%-3.39M
-19.29%-2.81M
24.73%-2.05M
47.26%-2.55M
22.61%-11.71M
37.67%-1.81M
5.90%-2.36M
24.25%-2.72M
21.36%-4.83M
Net income from continuing operations
10.72%-12.47M
-13.64%-5.31M
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
Operating gains losses
47.87%-2.96M
99.06%-54K
--87K
---3.07M
--84K
---5.67M
---5.74M
--0
----
----
Depreciation and amortization
-70.00%6K
300.00%4K
-50.00%1K
--0
-91.67%1K
-58.33%20K
-91.67%1K
-83.33%2K
-58.33%5K
0.00%12K
Other non cash items
-99.99%1K
-100.05%-4K
----
----
----
34,141.67%8.22M
136,733.33%8.21M
--0
-71.43%2K
20.00%6K
Change In working capital
476.46%4.4M
919.02%1.88M
38.39%739K
492.83%1.74M
102.11%46K
-100.00%-1.17M
-87.51%184K
-35.59%534K
117.04%293K
27.87%-2.18M
-Change in prepaid assets
9.38%70K
-66.57%231K
-57.57%157K
-64.13%184K
66.75%-502K
-83.84%64K
12.36%691K
160.56%370K
634.38%513K
-469.81%-1.51M
-Change in payables and accrued expense
451.22%4.33M
424.26%1.64M
254.88%582K
805.91%1.55M
181.91%548K
-25.71%-1.23M
-159.09%-507K
-76.13%164K
-195.24%-220K
75.73%-669K
Cash from discontinued investing activities
Operating cash flow
7.80%-10.8M
-87.77%-3.39M
-19.29%-2.81M
24.73%-2.05M
47.26%-2.55M
22.61%-11.71M
37.67%-1.81M
5.90%-2.36M
24.25%-2.72M
21.36%-4.83M
Investing cash flow
Cash flow from continuing investing activities
-725.00%-50K
-9K
-37K
0
-4K
101.37%8K
0
0
8K
0
Net PPE purchase and sale
-725.00%-50K
---9K
---37K
--0
---4K
366.67%8K
--0
--0
--8K
--0
Cash from discontinued investing activities
Investing cash flow
-725.00%-50K
---9K
---37K
--0
---4K
101.37%8K
--0
--0
366.67%8K
--0
Financing cash flow
Cash flow from continuing financing activities
-100.28%-80K
0
0
30.21%28.68M
123.61%28.82M
-458.33%-134K
Net preferred stock issuance
--0
----
----
----
----
--32.25M
----
----
----
----
Net other financing activities
97.76%-80K
--0
--0
----
----
-70.85%-3.57M
-196.89%-3.44M
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.28%-80K
--0
--0
---80K
--0
30.21%28.68M
123.61%28.82M
-458.33%-134K
--0
--0
Net cash flow
Beginning cash position
103.60%33.36M
306.50%25.84M
224.19%28.69M
166.62%30.81M
103.60%33.36M
62.42%16.39M
-8.99%6.36M
-6.98%8.85M
-11.34%11.56M
62.42%16.39M
Current changes in cash
-164.38%-10.93M
-112.60%-3.4M
-14.36%-2.85M
21.56%-2.13M
47.17%-2.55M
169.22%16.98M
187.20%27.01M
1.50%-2.49M
23.00%-2.71M
-263.64%-4.83M
Effect of exchange rate changes
----
----
----
----
--0
----
----
----
----
80.00%-1K
End cash Position
-32.76%22.44M
-32.76%22.44M
306.50%25.84M
224.19%28.69M
166.62%30.81M
103.60%33.36M
103.60%33.36M
-8.99%6.36M
-6.98%8.85M
-11.34%11.56M
Free cash flow
7.37%-10.85M
-88.27%-3.4M
-20.86%-2.85M
24.73%-2.05M
47.17%-2.55M
22.63%-11.71M
37.67%-1.81M
5.90%-2.36M
24.32%-2.72M
21.36%-4.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.80%-10.8M-87.77%-3.39M-19.29%-2.81M24.73%-2.05M47.26%-2.55M22.61%-11.71M37.67%-1.81M5.90%-2.36M24.25%-2.72M21.36%-4.83M
Net income from continuing operations 10.72%-12.47M-13.64%-5.31M-22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M13.51%-2.88M
Operating gains losses 47.87%-2.96M99.06%-54K--87K---3.07M--84K---5.67M---5.74M--0--------
Depreciation and amortization -70.00%6K300.00%4K-50.00%1K--0-91.67%1K-58.33%20K-91.67%1K-83.33%2K-58.33%5K0.00%12K
Other non cash items -99.99%1K-100.05%-4K------------34,141.67%8.22M136,733.33%8.21M--0-71.43%2K20.00%6K
Change In working capital 476.46%4.4M919.02%1.88M38.39%739K492.83%1.74M102.11%46K-100.00%-1.17M-87.51%184K-35.59%534K117.04%293K27.87%-2.18M
-Change in prepaid assets 9.38%70K-66.57%231K-57.57%157K-64.13%184K66.75%-502K-83.84%64K12.36%691K160.56%370K634.38%513K-469.81%-1.51M
-Change in payables and accrued expense 451.22%4.33M424.26%1.64M254.88%582K805.91%1.55M181.91%548K-25.71%-1.23M-159.09%-507K-76.13%164K-195.24%-220K75.73%-669K
Cash from discontinued investing activities
Operating cash flow 7.80%-10.8M-87.77%-3.39M-19.29%-2.81M24.73%-2.05M47.26%-2.55M22.61%-11.71M37.67%-1.81M5.90%-2.36M24.25%-2.72M21.36%-4.83M
Investing cash flow
Cash flow from continuing investing activities -725.00%-50K-9K-37K0-4K101.37%8K008K0
Net PPE purchase and sale -725.00%-50K---9K---37K--0---4K366.67%8K--0--0--8K--0
Cash from discontinued investing activities
Investing cash flow -725.00%-50K---9K---37K--0---4K101.37%8K--0--0366.67%8K--0
Financing cash flow
Cash flow from continuing financing activities -100.28%-80K0030.21%28.68M123.61%28.82M-458.33%-134K
Net preferred stock issuance --0------------------32.25M----------------
Net other financing activities 97.76%-80K--0--0---------70.85%-3.57M-196.89%-3.44M------------
Cash from discontinued financing activities
Financing cash flow -100.28%-80K--0--0---80K--030.21%28.68M123.61%28.82M-458.33%-134K--0--0
Net cash flow
Beginning cash position 103.60%33.36M306.50%25.84M224.19%28.69M166.62%30.81M103.60%33.36M62.42%16.39M-8.99%6.36M-6.98%8.85M-11.34%11.56M62.42%16.39M
Current changes in cash -164.38%-10.93M-112.60%-3.4M-14.36%-2.85M21.56%-2.13M47.17%-2.55M169.22%16.98M187.20%27.01M1.50%-2.49M23.00%-2.71M-263.64%-4.83M
Effect of exchange rate changes ------------------0----------------80.00%-1K
End cash Position -32.76%22.44M-32.76%22.44M306.50%25.84M224.19%28.69M166.62%30.81M103.60%33.36M103.60%33.36M-8.99%6.36M-6.98%8.85M-11.34%11.56M
Free cash flow 7.37%-10.85M-88.27%-3.4M-20.86%-2.85M24.73%-2.05M47.17%-2.55M22.63%-11.71M37.67%-1.81M5.90%-2.36M24.32%-2.72M21.36%-4.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg